Healthcare provider profile · identity verified

Derek Fritz, DO

Family Practice · GILBERT, AZ · NPI 1366904047

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	202	71
Levothyroxine Sodium	Levothyroxine Sodium	168	55
Losartan Potassium	Losartan Potassium	124	47
Amlodipine Besylate	Amlodipine Besylate	116	42
Rosuvastatin Calcium	Rosuvastatin Calcium	110	38
Trazodone Hcl	Trazodone Hcl	95	32
Fluticasone Propionate	Fluticasone Propionate	90	46
Albuterol Sulfate Hfa	Albuterol Sulfate	86	32
Gabapentin	Gabapentin	83	33
Lisinopril	Lisinopril	77	33
Tizanidine Hcl	Tizanidine Hcl	77	31
Montelukast Sodium	Montelukast Sodium	75	33
Omeprazole	Omeprazole	75	30
Tamsulosin Hcl	Tamsulosin Hcl	72	24
Metformin Hcl	Metformin Hcl	61	27
Metoprolol Tartrate	Metoprolol Tartrate	54	18
Simvastatin	Simvastatin	54	21
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Metoprolol Succinate	Metoprolol Succinate	51	23
Prednisone	Prednisone	45	29
Potassium Chloride	Potassium Chloride	43	14
Bupropion Xl	Bupropion Hcl	42	13
Famotidine	Famotidine	42	22
Eliquis	Apixaban	41	12
Mounjaro	Tirzepatide	40	suppressed
Jardiance	Empagliflozin	39	suppressed
Carvedilol	Carvedilol	36	13
Clopidogrel	Clopidogrel Bisulfate	36	11
Buspirone Hcl	Buspirone Hcl	35	17
Furosemide	Furosemide	35	15
Mupirocin	Mupirocin	35	20
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	18
Azithromycin	Azithromycin	32	27
Sertraline Hcl	Sertraline Hcl	32	suppressed
Alprazolam	Alprazolam	31	13
Metformin Hcl Er	Metformin Hcl	31	13
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Ozempic	Semaglutide	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	18
Pioglitazone Hcl	Pioglitazone Hcl	25	12
Lorazepam	Lorazepam	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Allopurinol	Allopurinol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Finasteride	Finasteride	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Nystatin	Nystatin	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Meloxicam	Meloxicam	18	13
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Glipizide	Glipizide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Valacyclovir	Valacyclovir Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Wegovy	Semaglutide	12	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error